Home Markets Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy

Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy

Jun 15, 2024 comments off

Original source: https://www.investing.com/news/stock-market-news/novo-nordisk-ceo-to-testify-in-us-senate-hearing-on-high-cost-of-ozempic-wegovy-3485707

You May Also Like

Apax, Nordic Capital and Dalmore circling UK supplier JLA Group – Bloomberg

Couche-Tard proposes up to $8 billion offer for Cumberland Farms, The Times reports

France spared Moody’s ratings downgrade as it struggles with unrest

Moonshot curbs hacking ability in new Kimi model as fears grow over AI-powered cyberattacks

Swiss stocks outperform Europe as investors retreat from AI trade – Bloomberg

France’s luxury stores board up windows ahead of fresh protests